(Q46682211)

24 December 2017

title

Newly diagnosed chronic granulomatous disease in a 53-year-old woman with Crohn disease (English)

1 reference

24 December 2017

chronic granulomatous disease

main subject

1 reference

2

Karen M Wolf

1 reference

24 December 2017

author name string

Srinivasan Ramanuja

1

1 reference

24 December 2017

Mohammed A Sadat

3

1 reference

24 December 2017

Stephen J Mahoney

4

1 reference

24 December 2017

Mary C Dinauer

5

1 reference

24 December 2017

Robert P Nelson

6

1 reference

24 December 2017

publication date

1 August 2005

1 reference

24 December 2017

Annals of Allergy, Asthma & Immunology

published in

1 reference

24 December 2017

volume

95

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

page(s)

204-209

1 reference

24 December 2017

Chronic granulomatous disease in adults

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Leukocyte oxidase: defective activity in chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

A Fatal Granulomatous Disease of Childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Fatal granulomatous disease of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Defective Polymorphonuclear-Leukocyte Function and Chronic Granulomatous Disease in Two Female Children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Fatal granulomatous disease of childhood and benign lymphocytic infiltration of the skin (congenital dysphagocytosis).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Studies of the Metabolic Activity of Leukocytes from Patients with a Genetic Abnormality of Phagocytic Function*

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Chronic granulomatous disease of childhood: a saga of discovery and understanding.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

X-linked inheritance in females with chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Chronic granulomatous disease. Report on a national registry of 368 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Immunodeficiency diseases caused by defects in phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Prostatitis in chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Urinary tract disorders in patients with chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Growth in patients with chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Phagocyte immunodeficiencies and their infections

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Lung abscess in adults: clinical comparison of immunocompromised to non-immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

The clinical spectrum of Staphylococcus aureus pulmonary infection

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Legionella pneumophila lung abscess in a patient with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Aspiration diseases: findings, pitfalls, and differential diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Clinical problem-solving. Unfashionably late

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Burkholderia cepacia epidemiology and pathogenesis: implications for infection control.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Clinical features of Pseudomonas cepacia pneumonia in an epidemic among immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Colitis in chronic granulomatous disease resembling Crohn's disease: comparative analysis of CD68-positive cells between two disease entities

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Colitis in chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Itraconazole to prevent fungal infections in chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Bone marrow transplantation for chronic granulomatous disease: long-term follow-up and review of literature

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961212-4

7 January 2021

10.1016/S1081-1206(10)61212-4

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017